ReviewCalcified tissue international2026
Ectodysplasin-A (EDA) Signaling Cross-Talk in Skeletogenesis.
Review in Calcified tissue international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skeletal morphogenesis is a highly complicated interaction cascade of molecular cues, with the Ectodysplasin-A (EDA) pathway emerging as a potentially important contributor to this biological process. This review focuses on the molecular complexity of the EDA pathway’s role in shaping the diverse skeletal architectures observed in vertebrate models studied to date, particularly in fish and mammals. At the molecular level, we first discuss the signaling cascades initiated by EDA and briefly explore its impact on skeletal development. Insights into the transcriptional regulation and downstream effectors activated by EDA provide a greater understanding of its influence on skeletal formation. Beyond its standalone role in skeletogenesis, the review mainly focuses on the dynamic cross-talk between the EDA pathway and other important skeletogenic/morphogenic pathways. The multi-layered interplay with signaling networks, such as BMP, Hedgehog, Wnt, and FGF, highlights the integration of this pathway into broader molecular process governing skeletal morphogenesis. The physiological role of EDA in skeletal tissues appears highly context-dependent, varying with the interacting pathway, cell type, and developmental stage. We explore instances where EDA acts as a conductor, harmonizing its effects with those of other pathways to achieve distinct outcomes in skeletal diversity, and propose a conceptual framework in which EDA integrates these inputs through shared transcriptional hubs, notably NF-κB and NFATc1, in a tissue- and stage-specific manner. By summarizing the interactions of EDA and their associated physiological roles, we provide a comprehensive perspective on the EDA-dependent molecular underpinnings of skeletal diversity, offering new and valuable insights for future research and potential applications in skeletal biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.